14oct(oct 14)1:00 am15(oct 15)1:00 amThe B-Cell Directed Therapies for Autoimmune Diseases Virtual SummitVirtual Hosted by: Hanson Wade

Hosted by

Hanson Wade

Event Details

Several clinical trials of B and plasma cell directed therapies are demonstrating positive results across a broad range of non-oncological, immune mediated diseases including systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and Sjogren’s syndrome. However, the vast potential of developing next generation B cell directed therapies remains challenging with limited fundamental knowledge on the role of B and plasma cell subtypes in health, autoimmunity and the wider immune system.

This virtual summit arrives as the first ever cross-disciplinary meeting for large pharma, biotech, and academia. This forum is dedicated to harnessing the full therapeutic opportunity of numerous candidates directed against various B and plasma cell targets (incl. CD20, PI3K, BTK & more). Come armed with questions, ideas and experiences and together, take steps to develop the next generation of B cell directed therapies to improve immune mediated disease management, define effective combination treatment regimens, and transform patient outcomes.


Oct. 14 to Oct. 15



Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy